• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Chinese regulators open medtech fast-track to foreign companies | MassDevice.com On Call

Chinese regulators open medtech fast-track to foreign companies | MassDevice.com On Call

February 13, 2014 By Arezu Sarvestani

MassDevice.com On Call

MASSDEVICE ON CALL — China’s Food & Drug Administration released new review guidelines allowing foreign companies to apply for the agency’s new "fast track" review, a pathway previously only accepting domestic applicants.

A draft version of the regulation, issued last year, referred only to domestic companies but the final notice published this month allows foreign companies to make use of the pathway as well, JD Supra reported.

Devices granted fast-track access will get priority throughout the regulatory process and will be assigned a "dedicated liaison" to get the application through the review process, according to the report.

Applicants must demonstrate that they are "innovative," as defined by invention patents filed in China, improved safety and performance compared to existing devices and other parameters.

 NASA analyzer heads to cancer ward
Scripps Translational Science Institute will begin testing a NASA-developed mobile chemical sensor that may be able to  detect the chemical signature of lung cancer.
Read more

 Cali groups working on transplantable retinas
California Stem Cell Inc. teamed up with the University of California, Irvine, to develop transplantable retinal tissue, funded by a $4.5 million grant from the California Institute of Regenerative Medicine.
Read more

 Feds show increasing interest in telehealth
Federal regulators are showing increasing interest in telehealth and remote patient monitoring, with hopes that new technologies will bring cost-savings and extend care to under-served areas.
Read more

 TransMedics gaining ground with "Lung in a Box"
Massachusetts-based TransMedics is making progress with its Organ Care System beginning with human lungs, keeping transplantable tissue "breathing" while en route to a transplant patient, rather than keeping the organ on ice.  
Read more

Filed Under: Emerging Markets, News Well, Regulatory/Compliance Tagged With: China Food & Drug Administration (CFDA), On Call

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy